Our ideas in the Mastercard and Boeing chains from yesterday’s report both played out very nicely for us, producing sizable intraday gain opportunities for ourselves and our readers. Here are the gains that have been made so far.
MA Weekly $272.50-277.50 Calls
$272.50: 6.03-13.00 (+116%)
$275: 4.58-10.75 (+135%)
$277.50: 3.25-8.74 (+169%)
BA Weekly $138-140 Calls
$138: 2.57-10.39 (+304%)
$139: 2.25-9.68 (+330%)
$140: 1.82-9.13 (+402%)
AMC Entertainment Holdings Inc. AMC – Update
We also got a new high in our AMC 06/19 $4 Calls, an options idea we formulated after our associate trader, Nicholas in VA, called our attention to the stock. These calls have now made a move .55-1.83 in just a couple of sessions, marking a total gain of 233%
MSFT Weekly $177.50-180 Calls
TSLA $840-860 Calls
SPY 05/04 $291-288 Puts
MCD Weekly $185 Puts
We also had a couple of stock calls from our extended watchlist produce some solid gain chances for us, which were as follows.
Ozop Surgical Corp. OZSC
Range: .0133-.0247 – Total Gain: 86%
Transportation and Logistics Systems, Inc. TLSS
Range: .0421-.094 – Total Gain: 123%
Vaxart Inc. VXRT – News Alert
We’ve been tracking VXRT pretty closely in recent weeks, and wanted to include a lonk to the coronavirus news the company put out this morning, which points to the company possible making some headway in the fight to develop a vaccine. It’s sending the stock on a ride in the premarket, and keeping us on high alert.
SOUTH SAN FRANCISCO, Calif., April 30, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose.(>>View Full PR)